GENE ONLINE|News &
Opinion
Blog

2025-11-03|

UC Santa Barbara Professor Omar Saleh Receives $441,000 NSF Grant to Study Electrically Charged Polymers

by GOAI
Share To

Omar Saleh, a materials professor and department chair at UC Santa Barbara, is conducting research into electrically charged polymers with funding from the National Science Foundation (NSF). The NSF has awarded Saleh a grant totaling $441,000 over three years to study complex coacervates—mixtures of charged polymers and oppositely charged molecules. His work focuses on understanding the fundamental properties of these materials, which are known for their ability to form liquid-like structures through electrostatic interactions.

Saleh’s research aims to uncover how these coacervates behave and interact at a molecular level. These mixtures have potential applications in various fields, including biotechnology and medicine. By investigating their unique properties, Saleh seeks to provide insights that could contribute to advancements in life-saving technologies. The NSF grant supports this effort by enabling detailed analysis of the physical and chemical behaviors of coacervates, which may lead to innovations in drug delivery systems or other medical applications.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 3, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top